NCT00435981View on ClinicalTrials.gov

Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

October 31, 2007

Study Completion Date

December 31, 2007

Conditions
Type 1 Diabetes
Interventions
DRUG

rhGAD65 formulated in Alhydrogel® (Diamyd®)

Trial Locations (8)

SE-501 82

Borås Hospital, Borås

SE-416 85

The Queen Silvia Children´s Hospital, Gothenburg

SE-301 85

Halmstad Hospital, Halmstad

SE-551 85

Ryhov Hospital, Jönköping

SE-581 85

Linköping University, Linköping

SE-205 02

University Hospital, MAS, Malmo

SE-701 85

Örebro University Hospital, Örebro

SE-171 76

Astrid Lindgren Children´s Hospital, Stockholm

Sponsors
All Listed Sponsors
lead

Diamyd Therapeutics AB

INDUSTRY

NCT00435981 - Efficacy and Safety of Diamyd® in Children and Adolescents With Type 1 Diabetes | Biotech Hunter | Biotech Hunter